The sole distributor for the purchase of medicines and medical products in the Republic of Kazakhstan held a working meeting with representatives of Pharm Aid LLC, a Russian pharmaceutical company specializing in the production of vaccines and oncological drugs.
The Russian side presented its product portfolio, including vaccines against rotavirus infection, chickenpox, meningococcus, as well as the antitumor drug Kadcyla (trastuzumab emtansine), used in the treatment of HER2-positive breast cancer.
Participants discussed how Pharm Aid products can enter the Kazakhstani market, what steps are needed to register medicines, and the procedure for purchasing medicines within the framework of the State Fund for Free Medical Care and the Compulsory Medical Insurance.
"It is important for us to cooperate with reliable and reputable partners. SK-Pharmacia LLP is a powerful player in the pharmaceutical market of Kazakhstan, and we are confident that cooperation with a single distributor will open up new opportunities for sustainable supplies and development of local presence," emphasized Azamat Metov, General Director of Pharm Aid LLP.
It is expected that the initiatives discussed during the meeting will form the basis for further negotiations aimed at increasing the availability of innovative and socially significant drugs for patients in Kazakhstan.
Источник: Казахстанский Фармацевтический Вестник, pharmnews.kz
The Russian side presented its product portfolio, including vaccines against rotavirus infection, chickenpox, meningococcus, as well as the antitumor drug Kadcyla (trastuzumab emtansine), used in the treatment of HER2-positive breast cancer.
Participants discussed how Pharm Aid products can enter the Kazakhstani market, what steps are needed to register medicines, and the procedure for purchasing medicines within the framework of the State Fund for Free Medical Care and the Compulsory Medical Insurance.
"It is important for us to cooperate with reliable and reputable partners. SK-Pharmacia LLP is a powerful player in the pharmaceutical market of Kazakhstan, and we are confident that cooperation with a single distributor will open up new opportunities for sustainable supplies and development of local presence," emphasized Azamat Metov, General Director of Pharm Aid LLP.
It is expected that the initiatives discussed during the meeting will form the basis for further negotiations aimed at increasing the availability of innovative and socially significant drugs for patients in Kazakhstan.
Источник: Казахстанский Фармацевтический Вестник, pharmnews.kz
